Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Cancer Biology & Therapy|July 22, 2011
Src family kinases mediate epidermal growth factor receptor signaling from lipid rafts in breast cancer cellsMary E Irwin, Natacha Bohin, Julie L BoernerAntioxidants & Redox Signaling|August 21, 2012
Redox control of leukemia: from molecular mechanisms to therapeutic opportunitiesMary E Irwin, Nilsa Rivera-Del Valle, Joya ChandraJournal of Cellular Physiology|June 11, 2011
Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinibMary E Irwin, Kelly L Mueller, Natacha Bohin, et al.Oncotarget|July 3, 2015
A NOX2/Egr-1/Fyn pathway delineates new targets for TKI-resistant malignanciesMary E Irwin, Blake P Johnson, Roxsan Manshouri, et al.Cancer Chemotherapy and Pharmacology|January 10, 2018
Combinatorial effects of histone deacetylase inhibitors (HDACi), vorinostat and entinostat, and adaphostin are characterized by distinct redox alterationsNilsa Rivera-Del Valle, Tiewei Cheng, Mary E Irwin, et al.Plos One|January 4, 2013
Expression and activity of Fyn mediate proliferation and blastic features of chronic myelogenous leukemiaMelissa M Singh, Adrienne Howard, Mary E Irwin, et al.Cancer|December 6, 2011
Inhibition of the NADPH oxidase regulates heme oxygenase 1 expression in chronic myeloid leukemiaMelissa M Singh, Mary E Irwin, Yin Gao, et al.Antioxidants (Basel, Switzerland)|April 23, 2022
Targeting the NRF2/HO-1 Antioxidant Pathway in FLT3-ITD-Positive AML Enhances Therapy EfficacySankaranarayan Kannan, Mary E Irwin, Shelley M Herbrich, et al.Plos One|August 13, 2013
Small molecule ErbB inhibitors decrease proliferative signaling and promote apoptosis in philadelphia chromosome-positive acute lymphoblastic leukemiaMary E Irwin, Laura D Nelson, Janice M Santiago-O'Farrill, et al.Pageof 1